Rheumatoid Arthritis Diagnosis Test Market Has Been Estimated to Be Valued at Us$ 485.5 Mn in 2015

Submitted by: Submitted by

Views: 10

Words: 6039

Pages: 25

Category: Business and Industry

Date Submitted: 05/15/2016 10:32 PM

Report This Essay

Global Rheumatoid Arthritis Diagnosis Tests Market: Increasing

Efficiency of RA Test Kits to Drive Growth of the Market during the

Forecast Period, 2015 - 2022

Persistence Market Research

Global Rheumatoid Arthritis Diagnosis Test

Market has been Estimated to be Valued at

US$ 485.5 Mn in 2015 - Persistence Market

Research

Persistence Market Research

1

Global Rheumatoid Arthritis Diagnosis Tests Market: Increasing

Efficiency of RA Test Kits to Drive Growth of the Market during the

Forecast Period, 2015 - 2022

Persistence Market Research Released New Market Report “Global Market Study on Rheumatoid

Arthritis Diagnosis Tests: Increasing Efficiency of RA Test Kits to Drive Growth of the Market

during the Forecast Period, 2015 – 2022’.

The rheumatoid arthritis diagnosis tests market is expected to be valued at US$ 738.7 Mn by the end of

2022, expanding at a CAGR of 6.2% during the forecast period (2016–2022). Based on type of tests, the

rheumatoid arthritis diagnosis tests market is segmented into serology test and treatment monitoring

tests. Increasing incidence of autoimmune diseases, off-label prescription of NSAIDs and other pain

management drugs are projected to increase demand for RA diagnosis. In addition, extensive focus on

the high specificity and sensitivity of RA kits from kit manufacturers and favorable regulatory guidelines for

rapid RA diagnostic kits are expected to fuel market growth. Commercialization of rapid diagnostic test,

especially in anti-CCP test would provide key growth opportunities for RA test kits manufacturers.

However, higher costs of these test kits and limited sensitivity when performed as individual test are major

restraining factors for this market. Revenue contribution of anti-CCP test segment has been estimated to

be the highest, accounting for 31.0% of the total rheumatoid arthritis market share in 2015 and is

expected to be one of the most lucrative segments over the forecast period. Limited sensitivity of other

tests such...